German Biotechnology Days 2018: Federal Economics Minister, BDI President and BMBF State Secretary recognise the role of biotechnology
The German biotechnology industry received a significant boost from politics and industry at the opening of the ninth edition of the German Biotechnology Days in Berlin on 18 April. With more than 1,000 registrations, the two-day event set a new record. The high-calibre program covered all major research and development areas in the industry sector.
Some 80 finance experts from the biotech scene discussed the current situation in financing innovations at the twelfth Biotech CFO Summit in Berlin.
As reported in the February newsletter, Germany’s National Working Group (NAKI) met to review the implementation of the EU’s new Regulation on medical devices (MDR) and in vitro diagnostic medical devices (IVDR) in German law.